Introduction {#Sec1}
============

Infertility is defined by the World Health Organization (WHO) as the inability to conceive after 1 year (or longer) of unprotected intercourse \[[@CR1]\]. Its prevalence has increased by 50% since the past decade, with rates ranging from 9 to 18% in different parts of the world \[[@CR2]\]. A systematic analysis of infertility incidence revealed that 1.9% of women experience primary infertility and 10.5% suffer from secondary infertility \[[@CR3]\]. Infertility among couples might originate from male factors (35%), tubal and pelvic pathology (35%), ovulatory dysfunction (15%), unexplained infertility (10%), and unusual problems (5%) \[[@CR4]\]. The WHO regards infertility as an important reproductive health problem that causes emotional, psychological, and social disorders \[[@CR1]\], but the invisibility of this condition means that it has stimulated minimal concern \[[@CR5]\] and has thus prevented afflicted individuals from exercising control over their lives \[[@CR6]\].

Having a child is of considerable importance to women, and when they are unable to conceive, they are often subjected to strong pressure from family members and relatives \[[@CR7]\]. Infertility threatens women's families and social statuses and, in some societies, may drive husbands to seek a divorce or re-marry \[[@CR8]\]. In many communities, infertility is considered a feminine condition, thereby rendering the condition a general stigma with devastating consequences. The actual and potential problems (emotional, psychological, and social disorders) stemming from infertility cause anxiety in women \[[@CR7], [@CR9]\] Part of that is due to the lack of infertility services in the primary health care system \[[@CR10]\]. Interventions are offered mostly at high costs in private clinics, thus restricting the availability of these services, especially in low- and middle-income countries \[[@CR11], [@CR12]\] Further pressure arises because women, especially in developing and low-income countries, are typically the recipients of tests and treatments, they are mostly unemployed, and men shoulder expenses related to therapies \[[@CR10], [@CR11]\]. The majority of infertility women are more likely to expose to negative effects on quality of life than men---a phenomenon that increases anxiety among affected female populations \[[@CR13]--[@CR15]\].

Most studies show that marital quality of infertile couples decreases and this can be related to the couple's anxiety symptoms \[[@CR11], [@CR12]\]. Few studies uncovered that the quality of marital relations between infertile couples is better than that between their fertile counterparts as the disease drives couples to be closer and reduces the associated apprehension \[[@CR16], [@CR17]\]. Nevertheless, infertility and its treatment continue to be important factors for anxiety among women because of the long-term nature of intervention and the unpredictability of success. The administration of medication and referring to a doctor can lead to anxiety \[[@CR18]\]. Apprehension can likewise be due to the difficulties associated with drug use and therapeutic measures, which in turn, affect the outcomes of infertility treatment \[[@CR19], [@CR20]\].

Global reports indicated differences in the prevalence of anxiety in infertile couples \[[@CR21]\] as infertile women experience a higher level of anxiety than that experienced by infertile men, and the inability to conceive affects anxiety prevalence among the former \[[@CR22]\]. The diversity in findings is reflected, for example, in the works of Alosaimi et al. \[[@CR23]\], Maroufizadeh et al. \[[@CR24]\], and Volgsten et al. \[[@CR25]\], who found that anxiety prevalence among infertile women in Saudi Arabia, Iran, and Sweden reached rates of 21.8, 58.1, and 14.8%, respectively. Despite the value presented by these studies, however, no meta-analytic research has been devoted to specifically outlining anxiety prevalence with regard to female factors. One of the goals of meta-analysis was to provide accurate and valid information on the basis of a large sample derived from the combination of studies; the insights obtained offer data that can help physicians and service providers develop interventions and treatments \[[@CR26]\]. Correspondingly, this study conducted a systematic review and meta-analysis to probe into the prevalence of anxiety symptoms in infertile women, with exclusive focus directed toward factors relevant to female populations.

Methods {#Sec2}
=======

Search strategies {#Sec3}
-----------------

The preferred reporting items for systematic reviews and meta-analyses (PRISMA) \[[@CR27]\] was used to identify and articulate the problem explored in this work, collect and analyze data, interpret the findings, and draw conclusions. We conducted a comprehensive search in international databases, namely, PubMed, the Cochrane Library, Web of Science, Scopus, PsycINFO, and Embase, as well as national databases, namely, SID and Magiran. A Google Scholar search was also performed. Relevant Persian and English articles published from the early 2000s to May 2019 were searched and extracted by two independent researchers on the basis of keywords (i.e., "anxiety," "anxiety disorders," "infertility," "prevalence," "epidemiology") that were combined using the AND and OR operators to ensure a comprehensive and complete search process. The details of the search strategy are in Additional file [1](#MOESM1){ref-type="media"}.

Inclusion and exclusion criteria {#Sec4}
--------------------------------

The inclusion criteria were as follows: cross-sectional studies, only female factor for infertility not male factor or both or unknown factors, female factor-based reports on anxiety prevalence in infertile women, Studies with valid measurement tool using a validated cutoff score or clinical interview, studies published from 2000 to 2019, studies that involved a minimum sample size of 30, and studies that had samples being of reproductive age (15--49 years), unable to achieve pregnancy following at least 1 year of unprotected intercourse, suffering from primary or secondary infertility, and lacking non-chronic diseases.

The exclusion criteria were lack of full access to articles, studies with irrelevant reports, similar studies, other types of research (review, meta-analysis, interventional, cohort, and case-control studies, etc.), studies on infertile men or couples wherein infertility factors were not distinguished (i.e., female factors, male determinants, both factors, or unknown factors), and studies featuring pregnancy in women initially diagnosed as infertile.

Data extraction {#Sec5}
---------------

Relevant Persian and English articles published from the early 2000s to 31 May 2019 were searched. The keyword search first yielded 282,760 articles. After the exclusion of identical studies, the titles and abstracts of the remaining articles were reviewed. When necessary, the main texts were examined. All the steps were independently evaluated by two reviewers, and a third reviewer was involved in case of disagreement. The required data, including the names of authors, years of publication, countries where the studies were conducted, sample sizes, anxiety prevalence in infertile women, types of tools used to measure anxiety (standard instruments or.

interviews for diagnostic purposes to determine anxiety), mean ages of women, and durations of infertility, were obtained.

Quality evaluation {#Sec6}
------------------

Wells et al. \[[@CR28]\], developed a valid and reliable checklist called the Newcastle--Ottawa Scale (NOS) to assess the quality of non-randomized studies through meta-analyses. The quality of the present research was evaluated using the modified version of the NOS by Zhang et al. \[[@CR29]\], which addresses five domains: the representativeness of a sample (Population contained a mixture of specialties at multiple sites or a single specialty at a single site), sample size (200 and greater than 200 participants or less than 200), non-respondents (Comparability between respondent and non-respondent characteristics was established, and the response rate was satisfactory), the ascertainment of anxiety (Validated measurement tool using a validated cutoff score or clinical interview), and the quality of descriptive statistics reporting Reported descriptive statistics to describe the population (e.g., age, sex) with proper measures of anxiety (e.g., standard deviation, standard error, range, percentage). Each domain is scored between 0 and 1. In the modified NOS, scoring ranges from 0 to 5, with scores ≥3 indicating a low risk of bias and scores \<3 denoting a high risk of bias. The quality evaluation was performed independently by two reviewers, and a third was involved in case of disagreement. Finally, articles that exhibited a low risk of bias were selected for the analyses (Additional file [2](#MOESM2){ref-type="media"}). All studies reviewed in this research were low-risk. Inter-rater reliability of reviewers regarding study relevancy was high (Kappa = 0.88).

Statistical analyses {#Sec7}
--------------------

To calculate the pooled prevalence of anxiety in infertile women, the Metan command in Stata (version 14) was run. The heterogeneity of the studies was determined using the I^2^ statistical index, which ranges from 0 to 100; the larger the index, the more heterogeneous the findings. The categories encompassed by the I^2^ index were defined by Higgins as low heterogeneity (25%), moderate heterogeneity (50%), and high heterogeneity (75%). A study heterogeneity \> 50% prompts the use of random effects models \[[@CR30]\]. To identify the origins of heterogeneity in the examined studies, meta-regression was used to inquire into the types of tools used to measure anxiety, the duration of infertility, and sample size. Sensitivity analysis was also conducted to determine the effect of each study on the final results; that is, a given study was excluded from the final analysis, and the results were compared with and without the inclusion of the aforementioned study. An Egger test was performed to examine publication bias, and a subgroup analysis was carried out on the basis of the World Bank's classification of countries by income and used the instruments. Because of small number of include studies, the significance level of statistical tests was set at 0.10.

Results {#Sec8}
=======

Fig. [1](#Fig1){ref-type="fig"} presents the flow diagram of the meta-analysis. As previously stated, an initial 282,760 articles were found using the keywords; the removal of duplicate studies yielded 27,887 works, which were screened on the basis of their titles and abstracts. A set of 118 relevant articles were obtained, after which a final sample of 13 cross-sectional studies were assessed in terms of quality after the exclusion of ineligible research. The quality assessment was performed independently by two reviewers (Fig. [1](#Fig1){ref-type="fig"}). Fig. 1Flow diagram of the search for studies subjected to meta-analysis

The selected studies encompassed one research each conducted in Nigeria, Hungary, and Finland; two investigations each carried out in Norway, Sweden, and Saudi Arabia; and four studies performed in Iran. Five studies were performed in the context of low- and middle-income countries, and eight were conducted in high-income countries. The following instruments were used in the evaluated works: The Primary Care Evaluation of Mental Disorders (one study), the Munich-Composite International Diagnostic Interview (one study), the Spielberger Trait Anxiety Inventory (one study), Zung's Self-Rating Anxiety Scale (one study), the Mini International Neuropsychiatric Interview (two studies), the Cattle questionnaires (two studies), and the Hospital Anxiety and Depression Scale (five studies). The infertile women involved in the reviewed research numbered a total of 5055, and the sample size in each study ranged from 30 to 1413. The findings of the studies indicated that the maximum and minimum anxiety prevalence rates among the infertile women were 86.8 and 8.8%, respectively. Characteristics of the studies are shown in Table [1](#Tab1){ref-type="table"}. Table 1Characteristics of the studies selected for the meta-analysisIDAuthorsYears publishedCountriesIncome levelsSample sizesAges (Y) (mean ± SD)Mean years of infertility (mean ± SD)Types of tools usedQuality assessment1Volgsten et al. \[[@CR25]\]2008SwedenHigh41332.9 ± 3.93.27 ± 1.63PRIME-MD5/52Ramezanzadeh et al. \[[@CR19]\]2004IranLow and middle37028 ± 5.376.36 ± 4.18Cattle questionnaires3/53Klemetti et al. \[[@CR31]\]2010FinlandHigh23937.4 ± 0.45NAM-CIDI4/54Alosaimi et al. \[[@CR23]\]2015Saudi ArabiaHigh206NA5.4 ± 4.3MINI4/55Alshahrani et al. \[[@CR32]\]2019Saudi ArabiaHigh206NANAMINI4/56Maroufizadeh et al. \[[@CR24]\]2018IranLow and middle64931/37 ± 5.695.62 ± 4.03HADS4/57Joelsson et al. \[[@CR33]\]2017SwedenHigh46830.1 ± 4.81.8 ± 002HADS5/58Lakatos et al. \[[@CR34]\]2017HungaryHigh13433.30 ± 4.853.61 ± 3.08STAI-T4/59Biringer et al. \[[@CR35]\]2015NorwayHigh61535.15 ± 6.28NAHADS5/510Upkong and Orgi \[[@CR36]\]2006NigeriaLow and middle11234.5 ± 5.54.46 ± 3.73HADS4/511Rostad et al. \[[@CR37]\]2014NorwayHigh1413NANAHADS5/512Kalkhoran et al. \[[@CR38]\]2011IranLow and middle3029.2 0 ± 4.24.8 ± 0.5ZAS3/513Peyvandi et al. \[[@CR39]\]2009IranLow and middle20033.39 ± 0.24.1 ± 0.6Cattle questionnaires4/5*Abbreviations*: *PRIME-MD* Primary Care Evaluation of Mental Disorders, *NA* Not reported, *M-CIDI* Composite International Diagnostic Interview, Munich version, *MINI* Mini International Neuropsychiatric Interview, *HADS* Hospital Anxiety and Depression Scale, *STAI-T* Spielberger Trait Anxiety Inventory, *ZAS* Zung's Self-Rating Anxiety Scale

Evaluation of heterogeneity, publication bias and meta-regression {#Sec9}
-----------------------------------------------------------------

The I^2^ test results denoted heterogeneity in the studies (I^2^ = 99.3), thus compelling the use of a random effects model in the data analysis. The results of the Egger test indicated no evidence of publication bias (P ~Egger's\ Test~ = 0.406) (Fig. [2](#Fig2){ref-type="fig"}). To investigate the reasons for the heterogeneity in the assessed studies, three variables were introduced as covariance variables in the univariate meta-regression. The results revealed that sample size (*P* = 0.548), tool used (*P* = 0.691), and infertility duration (*P* = 0.554) were not accountable for the heterogeneity in the prevalence of anxiety in the infertile women. Fig. 2Plot of publication bias in relation to prevalence of anxiety

Meta-analysis {#Sec10}
-------------

The pooled prevalence of anxiety in the evaluated studies was 36.17% \[95% confidence interval (CI): 22.47--49.87\]. Klemetti et al. \[[@CR31]\]. and Ramezanzadeh et al. \[[@CR19]\] reported the lowest (8.8%; 95% CI: 5.21--12.39) and highest (86.80%; 95% CI: 83.35--90.25) anxiety prevalence rates for Finland and Iran, respectively (Fig. [3](#Fig3){ref-type="fig"}). Fig. 3Forest plot for estimating the pooled prevalence of anxiety among infertile women

Subgroup analysis {#Sec11}
-----------------

The review of the literature revealed that the prevalence of anxiety among infertile women is greater in the studies that used a questionnaire to diagnose anxiety symptoms. Hence, the instruments were classified into two groups: one comprising clinical interview and another questionnaire. The findings reflected that the pooled anxiety prevalence levels were 16.47% (95% CI:10.45--22.50) and 44.93% (95% CI: 26.85--63.29) in clinical interview and questionnaire, respectively (Fig. [4](#Fig4){ref-type="fig"}). Fig. 4Forest plot of the pooled prevalence of anxiety based on instruments

The review of the literature revealed that the prevalence of anxiety among infertile women is greater in low- and middle-income countries. Hence, the countries were classified into two groups: one comprising high-income nations and another consisting of low- and middle-income countries. The findings reflected that the pooled anxiety prevalence levels were 54.24% (95% CI: 31.86--78.62) and 25.05% (95% CI: 15.76--34.34) in low- and middle-income and high-income countries, respectively (Fig. [5](#Fig5){ref-type="fig"}). Fig. 5Forest plot of the pooled prevalence of anxiety based on country income

Discussion {#Sec12}
==========

This systematic and meta-analytic research evaluated prevalence of anxiety in infertile women on the basis of female factors. The results showed a prevalence rate of 36.17%, which is greater than the prevalence of the condition among the general public and healthy women. In a systematic review on anxiety prevalence in an adult population, the pooled prevalence of anxiety disorders was 3.8 to 25%%, 5.2 to 8.7% and 2.5 to 9.1%, respectively in adult population, women and young adults \[[@CR40]\]. In research performed in an international context, the pooled one-year and lifetime prevalence rates of total anxiety disorders were estimated at 10.6% (95% CI: 7.5, 14.3%) and 16.6% (95% CI: 12.7, 21.1%), respectively \[[@CR41]\].

Anxiety is a disturbing state that causes physical and mental stress in individuals over time \[[@CR42]\]. A review of studies conducted in many countries suggested that women endure the major burdens of infertility and experience intense anxiety from being blamed for their failure to give birth \[[@CR15]\]. Infertile women incur high costs from infertility treatments and suffer from problems caused by frequent visits to doctors, planned intercourse, and many other social issues, which strongly influence their mental health and anxiety levels \[[@CR7]\]. The prevalence rate found in the current research demonstrated that anxiety prevalence was higher among women who experience difficulty conceiving than among females in pre-and post-natal stages. In their systematic review, Sawyer et al. \[[@CR43]\] reported a 14.8% prevalence of anxiety in infertile women \[95% CI: 12.3, 17.4%\] and a 14% prevalence among women in pre- and post-natal periods \[95% CI: 12.9, 15.2%\]. In a meta-analysis conducted by Dennis et al. \[[@CR44]\], the prevalence of self-reported anxiety symptoms was 18.2% (95% CI: 13.6--22.8) in the first trimester of pregnancy, 19.1% (95% CI: 15.9--22.4) in the second trimester of pregnancy, 24.6% (95% CI: 21.2--28.0) in the third trimester of pregnancy, and 15.0% (95% CI: 13.7--16.4) in the first to 14th weeks of the post-natal period.

In most societies, having a child is closely related to the identity of a woman, and being a mother is equated with being a female \[[@CR11]\]. Under such perceptions, therefore, infertility brings women a sense of worthlessness, resulting in high levels of stress \[[@CR45]\]. Because pregnancy is a critical goal in women's lives, infertility causes a stronger sense of scarcity and anxiety in infertile women than their pregnant counterparts \[[@CR46]\]. Females who are unable to conceive perceive their social security to be at risk and become anxious because they foresee a future with no child to take care of them in old age or in case of illness \[[@CR47]\]. Note, however, that certain studies revealed no significant difference in anxiety levels between women undergoing reproductive health treatments and control groups, but such works inadequately elaborated on infertility-related factors (female and male determinants separately, both factors, unknown factors) \[[@CR12], [@CR48], [@CR49]\].

The anxiety prevalence rate found in the present study (i.e., 36.17%) is also greater than the prevalence rate found among infertile men. In Peterson et al.'s \[[@CR50]\] research on infertile men under treatment, for instance, 7% of the subjects reported experiencing anxiety. Alshahrani et al. \[[@CR32]\] found an anxiety prevalence of 20.5% among infertile males. Regardless of whether they or their husbands are the cause of infertility, women suffer from greater pressure than men; because of social prejudices, infertility is more likely to be viewed as a female problem so that women face more family problems than do men \[[@CR15]\] and are exposed to twice the risk of anxiety encountered by males \[[@CR40]\] Furthermore, untreated anxiety in women is associated with frequent visits to physicians, the failure of infertility treatments, and reduced social relations---problems that point to the need for serious attention and intervention \[[@CR51]\].

In the articles reviewed in the current meta-analysis, the prevalence of anxiety ranged from 8.8 to 86.8%, which reflect wide variations. Specific cases are those of Volgsten et al. \[[@CR25]\] and Klemetti et al. \[[@CR31]\], who reported prevalence levels of 8.8 and 14.8% in Sweden and Finland, respectively. Contrastingly, Upkong and Orgi \[[@CR36]\] and Maroufizadeh et al. \[[@CR24]\] found prevalence rates of 37.5 and 58.1% in Nigeria and Iran, respectively. The range also varied in the other studies as anxiety seemed more likely to prevail among infertile women in low-income countries. Hence, the subgroup analysis was based on the income of a given country in accordance with the World Bank's classification.

The subgroup analysis showed that the prevalence of anxiety in infertile women in middle- and low-income countries was almost twice as much as that in high-income countries. Social and economic status, social support, the quality of marital relationships, child-rearing culture, and the availability of health facilities were among the factors influencing the prevalence of anxiety, with the low- and middle-income countries facing numerous problems in these respects \[[@CR52], [@CR53]\] Such situation exacerbates the burden of disease and disability in the aforementioned regions \[[@CR54]\]. The annual spending of low-income countries on the treatment and prevention of mental diseases account for less than US\$2 per person, whereas that in high-income countries have a budget of more than US\$50 per year \[[@CR55]\]. Women, especially infertile females, in middle - and low-income nations not only grapple with anxiety and mental illness but also contend with inadequate treatment facilities given that their mental problems are unrecognized in many cases \[[@CR40]\]. In these countries, infertile women also experience high costs of infertility treatments and transportation to infertility centers, the lack of protective policies and regulations, and the lack of valuation from their families and communities \[[@CR10]\]. Following anxiety occurrence and the lack of diagnosis and treatment, the failure of infertility treatments and defective cycles in intervention might emerge \[[@CR56]\]. It is important to provide infertility policy based on the human rights framework \[[@CR47]\]. In a 1994 international conference on population and development, the condition was highlighted as a global problem and a cause of substantial loss to reproductive health \[[@CR57]\]. In the same vein, the WHO recommended the integration of infertility treatments into primary health services, especially in countries with low and medium income levels \[[@CR1]\].

In a 2015 meta-analysis aimed at assessing the effectiveness of psychosocial interventions in infertile women and men, meta-regression findings revealed that decreased anxiety is associated with excellent pregnancy rates \[[@CR42]\]. Anxiety is globally recognized as an important determinant of low health and involvement in the use of health services \[[@CR58]\]. Organizing support groups for infertile women and providing psychological interventions that emphasize training on coping skills, cognitive behavioral therapy, and anxiety management can exert positive effects on anxiety control in infertile women and their treatment process \[[@CR24]\].

The main limitations of the articles were their failure to distinguish between infertility-related factors and ascertain the mean values and standard deviations of anxiety measurement tools; these values could not be converted into prevalence rates. On the other hand, there is the diversity of instruments to determine the prevalence of anxious symptoms or anxiety in our study. This element, however, cannot be overlooked because the questionnaires provide quantitative information that can be analyzed and diagnosis cannot be made from these evaluations to the patients. Along with the questionnaire, clinical interviews should be considered for a more accurate diagnosis. Another shortcoming was the use of various instruments for assessing anxiety, in a general population. None of the tools was developed specifically to investigate incidence regarding female factors. Considering the various physical, psychological, and social differences among women and their exposure to infertility problems, the development of a specific questionnaire is essential. Generally, the definition of anxiety used is questionable because anxiety does not necessarily mean disturbance. In fact, it is a psychophysiological defense mechanism. The disorder appears when the intensity is extreme and frequent. There is no proportion between the stimulus that causes it and the symptomatology.

Conclusion {#Sec13}
==========

The results of the systematic review and meta-analysis showed that the prevalence of anxiety symptoms in infertile women with female factors was 36.17%, which is greater than the rate found for the general population, pregnant women, and men. The effects that anxiety poses on quality of life, marital relations, therapeutic outcomes, and women's authority in the family require serious consideration and intervention, especially in low- and middle-income countries. Despite extensive advances in this field, many issues remain unexplored, thus hindering the development of interventions intended to support infertile women and provide positive supportive measures to ensure positive outcomes during the therapeutic process.
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